Nightingale Health Oyj B (HEALTH)
Helsinki Exchange · Finland · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 1.225 |
|---|---|
| 52-week range | 0.786 – 2.595 |
| Return, 1 month / 3 months | +38.9% / +48.3% |
| Return, 1 year / 3 years | −47.2% / +16.9% |
| Trend | Uptrend |
| RSI (14) | 60 |
| Volatility (1 year) | 55.7% |
| Worst drawdown (1 year) | -68.5% |
| Average daily value traded | 0.09M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Nightingale Health Oyj is a Finnish health technology company based in Helsinki. It develops blood analysis technology that measures a broad range of biomarkers from a single blood sample, using nuclear magnetic resonance spectroscopy. The company provides blood testing and metabolic profiling services to healthcare providers, researchers and employers, with the aim of assessing risk related to chronic diseases such as heart disease and diabetes. Its customers include healthcare organisations and research institutions that use the results for prevention and health monitoring.
On this site Nightingale Health Oyj B appears as a stock on the Helsinki Exchange (Finland), code HEALTH, with prices in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Nightingale Health Oyj B (HEALTH) trades on the Helsinki Exchange in Finland. It last closed at EUR 1.225 on 22 October 2026.
Its price-based Market X-Ray is 36 out of 100 (a weak price profile), ranking 143 of 190 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 47.2% and over the last three months it rose 48.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Helsinki Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 33 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 5.4% | ||
| From 52-week high | -51.6% | ||
| Momentum | 55 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 48.3% | ||
| 6-month return | -1.2% | ||
| 12-month return, skipping the last month | -62.0% | ||
| Stability (higher is calmer) | 10 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 55.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -68.5% | ||
| Liquidity | 53 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.09M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +7.0% |
|---|---|
| 1 month | +38.9% |
| 3 months | +48.3% |
| 6 months | −1.2% |
| 1 year | −47.2% |
| 3 years | +16.9% |
| 5 years | −64.4% |
Signals
| 50-day / 200-day average | 1.008 / 1.162 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.083 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Helsinki Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.